Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Test Gel 5% vs ACZONE Gel 5% in Acne Vulgaris
NCT02929719Phase 1Completed
- Start
- Apr 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of dapsone in acne vulgaris (3 arms). Primary endpoints: Change in inflammatory lesion count at 12 weeks and Change in non-inflammatory lesion count at 12 weeks. Started Apr 2014; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02929719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02929719.